XML 28 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jul. 02, 2011
Jun. 30, 2012
Jul. 02, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense recognized $ 1,153 $ 3,328 $ 2,408 $ 4,736
Unrecognized Compensation Cost 7,475   7,475  
Expiration date of the 2007 stock incentive plan     May 22, 2017  
Maximum number of shares granted under restricted stock, unrestricted stock, RSU's and stock options to officers, employees and employee directors (in shares) 3,000,000   3,000,000  
Outstanding:        
Balance     384,000  
Balance (in dollars per share)     $ 15.40  
Granted (in shares)     0  
Granted (in dollars per share)     $ 0.00  
Exercised (in shares)     (22,095)  
Exercised (in dollars per share)     $ 7.89  
Cancelled or forfeited (in shares)     (232,000)  
Cancelled or forfeited (in dollars per share)     $ 16.29  
Balance 130,000   130,000  
Balance (in dollars per share) $ 15.08   $ 15.08  
Weighted average remaining contractual life of options outstanding at June 30, 2012     4 years  
Vested and expected to vest [Abstract]        
Vested and expected to vest (in shares) 130,000   130,000  
Vested and expected to vest (in dollars per share) $ 15.08   $ 15.08  
Remaining contractual term of options, vested and expected to vest at June 30, 2012     4 years  
Exercisable (in shares) 99,000   99,000  
Exercisable (in dollars per share) $ 14.88   $ 14.88  
Remaining contractual term of options, exercisable at June 30, 2012     3 years 8 months 8 days  
Share-based compensation arrangement by share-based payment award, options, vested during period (in shares)     30,000  
Share-based compensation arrangement by share-based payment award, options, non-vested, outstanding (in shares) 31,000   31,000  
Share-based compensation arrangement by share-based payment award, options, non-vested, weighted average grant date fair value (in dollars per share) $ 10.07   $ 10.07  
Stock price per share (in dollars per share) $ 9.43   $ 9.43  
Share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value 0   0  
Stock options exercised (in shares)     22,095  
Intrinsic value under share based compensation scheme     110  
Outstanding:        
Balance (in shares)     891,000  
Balance (in dollars per share)     $ 12.58  
Granted (in shares)     437,000  
Granted (in dollars per share)     $ 12.31  
Vested (in shares)     (12,000)  
Vested (in dollars per share)     $ 8.29  
Cancelled or forfeited (in shares)     0  
Cancelled or forfeited (in dollars per share)     $ 0.00  
Balance (in shares) 1,316,000   1,316,000  
Balance (in dollars per share) $ 12.53   $ 12.53  
Expected to vest at June 30, 2012 (in shares) 1,316,000   1,316,000  
Number of RSUs with performance-based vesting criteria expected to vest 324,000   324,000  
Number of RSUs with performance-based vesting criteria expected to vest 233,000   233,000  
Number of RSUs with performance-based vesting criteria expected to vest 276,000   276,000  
Outstanding:        
Balance (in shares)     87,000  
Granted (in shares)     10,000  
Granted (in dollars per share)     $ 9.33  
Redeemed for common stock     0  
Balance (in shares) 97,000   97,000  
Stock Options [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense recognized 20 (245) 47 (125)
Unrecognized Compensation Cost 44   44  
Weighted Average Remaining Amortization Periods     10 months 24 days  
Equity Awards Vested Upon The Passing Of Dr. Felix Zandman       77,334
Restricted Stock Units (RSUs) [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense recognized 1,133 3,573 2,268 4,639
Unrecognized Compensation Cost 7,431   7,431  
Weighted Average Remaining Amortization Periods     1 year 7 months 6 days  
Equity Awards Vested Upon The Passing Of Dr. Felix Zandman       98,375
Phantom Stock Units [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense recognized 0 0 93 222
Unrecognized Compensation Cost $ 0   $ 0  
Weighted Average Remaining Amortization Periods     0 years  
Maximum number of shares granted under restricted stock, unrestricted stock, RSU's and stock options to officers, employees and employee directors (in shares) 300,000   300,000  
Performance Vested Restricted Stock Units [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Equity Awards Vested Upon The Passing Of Dr. Felix Zandman       202,330